CBD clinical trials at UCSD
1 research study open to eligible people
Showing trials for
Efficacy of Inhaled Cannabis for Acute Migraine Treatment
open to eligible people ages 21-65
This crossover study will evaluate 3 different treatments of vaporized cannabis (THC, THC/CBD mix, and CBD) and vaporized placebo cannabis for the acute treatment of migraine.
La Jolla, California
Last updated: